Virus DNX2401 and Temozolomide in Recurrent Glioblastoma

Clinical trial NCT01956734 · COMPLETED

Trial details

NCT number: NCT01956734
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Recurrent Tumor

Start date: 2013-09-01
Primary completion: 2015-12-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.